Proyeksi Harga IBRN & Analisis ETF - Dividen·Biaya Pengelolaan·Komposisi Saham·NAV·RSI·MACD | Saham AS Hari Ini
Tabel metrik lengkap
| Category | Global or ExUS Equities - Industry Sector | Expense | 0.47% | Return% 1Y | 15.84% | Total Holdings | 81 | Perf Week | -4.48% | Volume | 321 |
| Asset Type | Equities (Stocks) | AUM | $6M | Return% 3Y | 16.09% | NAV | $31.87 | Perf Month | -17.38% | Avg Volume | 0.00M |
| ETF Type | Global Equities | Dividend TTM | $0.32 (1.02%) | Return% 5Y | - | 52W High | -27.01% | Perf Quarter | -19.61% | Rel Volume | 0.11 |
| Active/Passive | Passive | Div Gr. 3/5Y | - | Return% 10Y | - | 52W Low | 14.56% | Perf Half Y | -7.93% | Prev Close | $31.86 |
| IPO | 2022/8/26 | Flows% 1M | 0% | Return% SI | 6.89% | RSI (14) | 18.12 | Perf YTD | -2.87% | Price | $31.39 |
| Beta | 0.66 | Flows% 3M | 42.58% | Flows% YTD | 42.58% | Flows% 1Y | 42.58% | Perf Year | 12.02% | Volatility(W/M) | 0.99% 0.95% |
| SMA20 | -8.17% | SMA50 | -15.27% | SMA200 | -9.93% | ATR | 0.56 | ||||
iShares Neuroscience and Healthcare ETFIBRN | NYSE | Sektor kesehatan iShares Neuroscience and Healthcare ETF seeks to track the NYSE FactSet Global Neuro Biopharma and MedTech Index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience. The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index. It is non-diversified.
10 terbesar mencakup 56% dari dana
DNTH Dianthus Therapeutics Inc 5.34% 3 
XENE Xenon Pharmaceuticals Inc 4.87% 4 
PRAX Praxis Precision Medicines Inc 4.87% 5 
ACAD ACADIA PHARMACEUTICALS INC. 4.69% 6 
ARWR ARROWHEAD PHARMACEUTICALS, INC. 4.65% 7 
ALKS ALKERMES PUBLIC LIMITED COMPANY 4.60% 8 
SRRK Scholar Rock Holding Corp 4.29% 9 
BIIB BIOGEN INC. 4.18% 10 
NBIX NEUROCRINE BIOSCIENCES, INC. 4.09% Sektor dengan bobot terbesar lebih dulu.
Dalam 1 tahun terakhir, sedang
27% di bawah harga tertinggi 1 tahun.
Diperdagangkan lebih sedikit dari biasanya Itu 11% dari volume rata-ratanya.
Kinerja jangka panjangnya cenderung datar
Jika dibeli 3 tahun lalu, imbal hasil Anda sekarang +48.4%.
Ketuk untuk melihat angka
Harganya bergerak besar
Pada titik terburuk (November 2024) turun 35% dan butuh 191 hari untuk pulih.
Ketuk untuk melihat angka
Dividennya tergolong kecil
Membagikan dividen sebesar 1.02% per tahun.
Ketuk untuk melihat angka
Uang terus masuk
Selama setahun terakhir, uang baru setara 42.6% aset masuk.
Ketuk untuk melihat angka
CURE Direxion Daily Healthcare Bull 3X ETF 162M 
RXL ProShares Ultra Health Care 2X Shares 94M 
XLVI State Street Health Care Select Sector SPDR Premium Income ETF 28M 
RXD-1× ProShares UltraShort Health Care -2x Shares 4M 
TBXU Direxion Daily Biotech Top 5 Bull 2X ETF 3M 
BBH VanEck Biotech ETF 0.35% 
IDNA iShares Genomics Immunology and Healthcare ETF 0.47% 
MEDI Harbor Health Care ETF 0.8% 
GDOC Goldman Sachs Future Health Care Equity ETF 0.75% 
MEDX Horizon Kinetics Medical ETF 0.85% 
HAUZ Xtrackers International Real Estate ETF 0.1% 
VNQI Vanguard Global ex-U.S. Real Estate ETF 0.12% 
PBPH Portfolio Building Block World Pharma and Biotech Index ETF 0.13% 
Pertanyaan umum
Berapa jumlah saham yang dimiliki IBRN?
IBRN memiliki total 81 saham, dengan AUM sekitar $6M.
Apakah IBRN memberikan dividen (distribusi)?
Tingkat distribusi IBRN sekitar 1.02%.
Berapa tertinggi dan terendah 52 minggu IBRN?
IBRN mencatat tertinggi $43.01 dan terendah $27.40 dalam 52 minggu terakhir.
